Compare Alcon AG (ALC) vs Burlington Stores Inc (BURL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Burlington Stores Inc — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while Burlington Stores Inc trades at $316.42 (market cap $19.90B). The key difference: Alcon AG is the larger of the two by market cap, and Alcon AG pays a 0.54% dividend while Burlington Stores Inc pays none. Which is the better fit depends on your goals.
| ALC | BURL | |
|---|---|---|
Market Cap | $32.69B | $19.90B |
Sector | Health | Consumer Cyclical |
52-Week High | $92.22 | $347.82 |
52-Week Low | $62.02 | $242.43 |
Enterprise Value | $36.28B | $25.02B |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Burlington Stores (BURL) trades at $312.36, showing modest daily decline of -0.26% but maintaining strong fundamental performance with consistent earnings beats. The stock exhibits bearish technical signals despite positive analyst sentiment, with 94% buy ratings and a $364.40 consensus price target. Recent Q1 2026 results exceeded expectations with $2.01 EPS versus $1.80 expected, marking the 14th consecutive quarter of double-digit earnings growth.
BURL presents a compelling growth story with expanding margins and store expansion plans, though technical indicators suggest near-term caution. The stock's premium valuation (P/E 32.14) reflects growth expectations, while competitive pressures and consumer spending sensitivity remain key risks. Upside potential exists toward analyst targets if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Burlington Stores Inc
Burlington is a leading off-price retailer in the US, offering branded apparel, footwear, and home goods at significant discounts. It operates hundreds of stores focused on delivering high-quality products at great value.
Read more on BURL →
